Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Milestones in the Chronic Pain Market’s Growth Trajectory From 2025 To 2034?

In recent times, the market size for chronic pain has witnessed significant growth. It is projected to rise from $78.79 billion in 2024 to $84.66 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this increase during the historic period include injury and trauma, surgical procedures, inflammatory conditions, nerve damage and neuropathy, as well as the absence of efficient treatments.

In the upcoming years, the chronic pain market is anticipated to experience substantial expansion, escalating to $117.03 billion by 2029 with a compound annual growth rate (CAGR) of 8.4%. Factors contributing to the growth during the forecast period encompass aging populace, expansion of telemedicine, increased public health awareness, advancements in genetic research and personalized medicine, and psychosocial stress factors. Dominant trends predicted for the forecast period involve the incorporation of wearable technology, emergence of pain education and support groups, comprehensive pain management techniques, non-narcotic pain control methods, and the use of regenerative medicine for pain treatment.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11970&type=smp

What External and Internal Drivers Are Contributing to the Growth of theChronic Pain Market?

The growth of the chronic pain market is largely spurred on by the high rate of individuals suffering from long-term or persistent pain that surpasses the usual duration of healing, often extending beyond three months. This prevalence provides a significant market for breakthrough innovations in effective pain management strategies encompassing pharmaceutical and medical device solutions. For instance, the Australian Institute of Health and Welfare made a revelation in June 2024 that approximately 4.0 million Australians, about 16% of the population, had been struggling with back problems in 2022. Consequently, by 2023, back ailments had escalated to the third foremost cause of disease burden, accounting for 4.3% of the nation’s total disease burden. Moreover, a February 2024 report by the Institute for Health Metrics and Evaluation, a prominent American public health and research body, predicts that global cases of neck pain will surge to 269 million by 2050 (ranging from 219 to 322 million), signifying a 32.5% rise (between 23.9% and 42.3%) compared to 2020. Hence, the marked frequency of chronic pain sufferers plays a critical role in fuelling the growth of the chronic pain industry.

What Segment Types Define the Chronic Pain Market Structure?

The chronic painmarket covered in this report is segmented –

1) By Product: Drug; Devices

2) By Indication: Neuropathic Pain; Arthritis Pain; Chronic Back Pain; Cancer Pain; Migraine; Fibromyalgia; Other Indications

3) By End User: Hospitals; Clinics; Research Organization

Subsegments:

1) By Drug: Non-Opioid Analgesics; Opioids; Antidepressants; Anticonvulsants; Topical Analgesics; Corticosteroids

2) By Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Units; Spinal Cord Stimulators; Intrathecal Drug Delivery Systems; Heat And Cold Therapy Devices; Bioelectronic Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=11970&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Chronic Pain Market?

North America was the largest region in the chronic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Chronic Pain Market?

Emerging technologies for alternative pain management are becoming a major trend in the chronic pain industry. Firms in this market are investing their efforts in creating cutting-edge, portable, and easy-to-use nerve stimulation devices that utilize electrical impulses to activate nerves and lower pain, giving a non-invasive alternative for managing pain, to maintain their strong market standing. For example, in December 2022, Abbott Laboratories, an American healthcare firm with expertise in diagnostics, medical devices, nutrition, and patented generic drugs, introduced Eterna, a groundbreaking spinal cord stimulation (SCS) system that currently holds the title as the smallest implantable and rechargeable device in the chronic pain treatment market. Eterna SCS utilizes Abbott’s exclusive low-dose BurstDR stimulation, the only waveform technology with significant clinical proof (1A evidence), showing a 23% higher reduction in pain compared to standard waveform technology methods.

View the full report here:

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

What Is the Definition of the Chronic Pain Market?

Chronic pain refers to persistent or long-lasting pain that continues beyond the normal healing process of an injury or illness. Chronic pain can have various causes, including injuries, underlying medical conditions, nerve damage, inflammation, musculoskeletal disorders, and certain diseases such as arthritis, fibromyalgia, or neuropathy.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11970

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model